PLoS ONE 11:e0157855
There was no suspected any other allergens such as drug or food exposure as well as the patients did not have any signs or symptoms related to any concomitant infections
For a clinic that injects patients, there is added risk: administering a product that has not been assessed for identity, purity or sterility can cause real harm, and the clinic, not the overseas supplier, is the party a regulator and an injured patient will pursue
New asthma biomarkers: lessons from murine models of acute and chronic asthma
5.1 Mechanisms of synergy with conventional therapeutics SFNs multi-targeted nature makes it an ideal candidate for combination therapy, as it can sensitize cancer cells to conventional treatments through several complementary avenues
KLOW does not appear to be an International Nonproprietary Name, a British Approved Name, a pharmacopoeial monograph or a recognised name for a defined chemical entity